Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Cabot Corp Market Cap
From what 5 stock analysts predict, the share price for Cabot Corp (CBT) might increase by 7.28% in the next year. This is based on a 12-month average estimation for CBT. Price targets go from $105 to $127. The majority of stock analysts believe CBT is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
Cabot Corp has a total of 5 Wall St Analyst ratings. There are 2 buy ratings, 2 ratings, and 1 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Cabot Corp will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of CBT.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Jeffrey Zekauskas JP Morgan | Underweight | $105 | Downgrade | Nov 11, 2024 |
| John Roberts Mizuho | Outperform | $122 | Maintains | Nov 5, 2024 |
| Jeffrey Zekauskas JP Morgan | Neutral | $105 | Maintains | Aug 7, 2024 |
| Joshua Spector UBS | Neutral | $98 | Maintains | Aug 6, 2024 |
| Joshua Spector UBS | Neutral | $103 | Maintains | May 7, 2024 |
| John Roberts Mizuho | Buy | $109 | Maintains | May 7, 2024 |
| David Begleiter Deutsche Bank | Hold | $95 | Downgrade | Apr 18, 2024 |
| John Roberts Mizuho | Buy | $104 | Initiates | Mar 27, 2024 |
| Joshua Spector UBS | Neutral | $87 | Downgrade | Jan 8, 2024 |
| Joshua Spector UBS | Buy | $90 | Maintains | Dec 14, 2023 |
| Joshua Spector UBS | Buy | $83 | Maintains | Nov 7, 2023 |
| Jeffrey Zekauskas JP Morgan | Neutral | $70 | Maintains | Aug 11, 2023 |
| John Roberts Credit Suisse | Outperform | $82 | Maintains | Aug 8, 2023 |
| Christopher Kapsch Loop Capital | Buy | $103 | Maintains | Jun 20, 2023 |
JP Morgan | Neutral | Downgrade | Jun 6, 2023 | |
| David Begleiter Deutsche Bank | Buy | $80 | Maintains | May 18, 2023 |
| John Roberts Credit Suisse | Outperform | $91 | Maintains | May 9, 2023 |
| John Roberts Credit Suisse | Outperform | $94 | Initiates | Mar 13, 2023 |
| Jeffrey Zekauskas JP Morgan | Overweight | $87 | Maintains | Feb 13, 2023 |
| Christopher Kapsch Loop Capital | Buy | $113 | Maintains | Feb 13, 2023 |
When did it IPO
1980
Staff Count
4,268
Country
United States
Sector/Industry
Basic Materials/Specialty Chemicals
CEO
Mr. Sean D. Keohane
Market Cap
$5.96B
In 2023, CBT generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that CBT's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Fri, 08 Nov 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Cabot Corporation (NYSE: CBT) declared a quarterly dividend of $0.43 per share, payable on December 13, 2024, to shareholders on record as of November 29, 2024.
Why It Matters - Cabot Corporation's dividend declaration signals financial stability and profitability, potentially attracting income-focused investors and boosting share price.
Thu, 07 Nov 2024
Sentiment - NEGATIVE
Source - Zacks Investment Research
Summary - CBT's Reinforcement Material segment experienced a Q4 EBIT decline attributed to lower volumes in the Americas, an unfavorable regional mix, and increased costs.
Why It Matters - The decline in EBIT signals potential revenue challenges and increased costs for CBT, which may impact profitability and investor sentiment.
Tue, 05 Nov 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - Cabot Corporation (NYSE: CBT) will host its Q4 2024 Earnings Conference Call on November 5, 2024, at 8:00 AM ET, featuring key executives and financial analysts.
Why It Matters - The Cabot Corporation Q4 2024 earnings call provides insights into the company's financial performance, strategic direction, and market conditions, influencing investor sentiment and stock valuation.
Mon, 04 Nov 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Cabot Corp has released its fourth quarter results for fiscal 2024, providing insights into its financial performance. Further details would be needed for specific data.
Why It Matters - Cabot Corp's quarterly results can impact stock performance, reveal financial health, and influence investor sentiment, affecting future investment decisions.
Mon, 04 Nov 2024
Sentiment - NEGATIVE
Source - Zacks Investment Research
Summary - Cabot (CBT) reported Q3 earnings of $1.80 per share, missing the Zacks Consensus Estimate of $1.82. This reflects an increase from $1.65 per share in the same quarter last year.
Why It Matters - Cabot's earnings miss signals potential operational challenges, impacting investor confidence. Year-over-year growth may not offset concerns over meeting expectations.
Mon, 14 Oct 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Zacks emphasizes its Rank system based on earnings estimates and revisions to identify strong stocks, while also monitoring value, growth, and momentum trends for investment insights.
Why It Matters - Zacks' focus on earnings estimates and revisions highlights potential stock performance, guiding investors to identify strong value, growth, and momentum opportunities.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
